CRYSTALLINE SALT FORM OF (S)-(2-(6-CHLORO-7-METHYL-1H-BENZO[D]IMIDAZOL-2-YL)-2-METHYLPYRROLIDIN-1-YL)(5-METHOXY-2-(2H-1,2,3-TRIAZOL-2-YL)PHENYL)METHANONE AS OREXIN RECEPTOR ANTAGONIST
BOSS CHRISTOPH,BROTSCHI CHRISTINE,GUDE MARKUS,HEIDMANN BIBIA,SIFFERLEN THIERRY,VON RAUMER MARKUS,WILLIAMS JODI T.
申请号：
PL14824108
公开号：
PL3077390T3
申请日:
2014.12.02
申请国别(地区):
PL
年份:
2018
代理人:
摘要：
The invention relates to a crystalline form of (S)-(2-(6-chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone hydrochloride, processes for the preparation thereof, pharmaceutical compositions containing said crystalline form, and its use as medicament, especially as orexin receptor antagonist.
